Mettler-Toledo International Inc. (NYSE:MTD) Director Robert F. Spoerry sold 1,960 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $721.00, for a total value of $1,413,160.00. Following the transaction, the director now owns 8,108 shares in the company, valued at $5,845,868. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Mettler-Toledo International stock opened at $748.31 on Friday. Mettler-Toledo International Inc. has a twelve month low of $579.40 and a twelve month high of $873.51. The stock’s fifty day simple moving average is $704.51 and its 200-day simple moving average is $736.56. The company has a current ratio of 1.77, a quick ratio of 1.34 and a debt-to-equity ratio of 4.94. The firm has a market capitalization of $17.59 billion, a P/E ratio of 33.81, a P/E/G ratio of 5.77 and a beta of 1.05.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $4.00 EPS for the quarter, beating the consensus estimate of $3.89 by $0.11. The firm had revenue of $649.20 million for the quarter, compared to analyst estimates of $651.78 million. Mettler-Toledo International had a return on equity of 134.62% and a net margin of 18.38%. Mettler-Toledo International’s revenue for the quarter was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.10 earnings per share. Sell-side analysts predict that Mettler-Toledo International Inc. will post 21.02 earnings per share for the current year.

A number of research firms have commented on MTD. Evercore ISI cut Mettler-Toledo International from an “in-line” rating to an “underperform” rating in a research note on Sunday, April 19th. Wolfe Research cut Mettler-Toledo International from a “market perform” rating to an “underperform” rating and set a $586.00 price target on the stock. in a research note on Thursday, April 2nd. Wells Fargo & Co upped their price target on Mettler-Toledo International from $690.00 to $760.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Citigroup upped their price target on Mettler-Toledo International from $725.00 to $740.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Finally, Cfra upped their price objective on Mettler-Toledo International from $705.00 to $741.00 and gave the stock a “hold” rating in a research report on Friday, May 8th. Three analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company. The stock has an average rating of “Hold” and an average price target of $722.20.

A number of large investors have recently bought and sold shares of the stock. Tiemann Investment Advisors LLC increased its holdings in Mettler-Toledo International by 5.3% in the fourth quarter. Tiemann Investment Advisors LLC now owns 300 shares of the medical instruments supplier’s stock valued at $238,000 after buying an additional 15 shares during the last quarter. Mission Wealth Management LP increased its holdings in Mettler-Toledo International by 3.9% in the fourth quarter. Mission Wealth Management LP now owns 424 shares of the medical instruments supplier’s stock valued at $336,000 after buying an additional 16 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in Mettler-Toledo International by 0.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,076 shares of the medical instruments supplier’s stock valued at $4,820,000 after buying an additional 16 shares during the last quarter. Exane Derivatives increased its holdings in Mettler-Toledo International by 2.2% in the first quarter. Exane Derivatives now owns 756 shares of the medical instruments supplier’s stock valued at $522,000 after buying an additional 16 shares during the last quarter. Finally, Smithfield Trust Co. increased its holdings in Mettler-Toledo International by 57.1% in the first quarter. Smithfield Trust Co. now owns 44 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 16 shares during the last quarter. 97.03% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

See Also: What are retained earnings?

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.